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Abstract
Background: Among clinical trials of interventions that aim to modify time spent on mechanical ventilation for
critically ill patients there is considerable inconsistency in chosen outcomes and how they are measured. The Core
Outcomes in Ventilation Trials (COVenT) study aims to develop a set of core outcomes for use in future ventilation
trials in mechanically ventilated adults and children.
Methods/design: We will use a mixed methods approach that incorporates a randomised trial nested within a
Delphi study and a consensus meeting. Additionally, we will conduct an observational cohort study to evaluate
uptake of the core outcome set in published studies at 5 and 10 years following core outcome set publication. The
three-round online Delphi study will use a list of outcomes that have been reported previously in a review of
ventilation trials. The Delphi panel will include a range of stakeholder groups including patient support groups. The
panel will be randomised to one of three feedback methods to assess the impact of the feedback mechanism on
subsequent ranking of outcomes. A final consensus meeting will be held with stakeholder representatives to
review outcomes.
Discussion: The COVenT study aims to develop a core outcome set for ventilation trials in critical care,
explore the best Delphi feedback mechanism for achieving consensus and determine if participation increases
use of the core outcome set in the long term.
Keywords: Consensus methods, Core outcome set, Critical care, Delphi technique, Mechanical ventilation
Background
The provision of mechanical ventilatory support with ac-
companying sedation is a major supportive therapy in
intensive care units (ICUs), but is not without potential
harms. In an attempt to minimise these, research has ex-
amined the effect of various interventions to reduce un-
necessary time receiving mechanical ventilation. These
interventions include sedation and ventilator weaning
protocols, and alternative ventilation modes. Systematic
reviews of trials spanning 20 years that evaluated
protocolised and automated weaning in adults and chil-
dren highlight variation in how outcomes were defined,
measured and reported [1–3]. Outcome variability is not
limited to trials of protocolised weaning. A systematic
review of 66 critical care trials that measured ventilation
as a primary or secondary outcome found outcome
reporting was not standardised [4]. Of 48 trials reporting
duration of mechanical ventilation, 75 % did not define
start and end points, and the remaining 25 % used vari-
able definitions. Furthermore, of 25 trials measuring
ventilator-free days, 36 % did not provide a definition,
that is, when counting of ventilator-free days com-
menced and ended; of those that did, again variability
was noted. Notably, although all 66 trials measured
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ventilation outcomes, no two trials used the same ‘set’ of
outcomes to do this.
It is evident there is a need for standardisation of out-
come selection and definitions, and difficulties raised by
inconsistent outcome reporting are increasingly recog-
nised. The Consolidated Standards of Reporting Trials
(CONSORT) statement 2010 [5] and the Standard Proto-
col Items: Recommendations for Interventional Trials
(SPIRIT) statement 2013 [6] both explicitly advocate the
use of ‘core outcome sets’ to achieve consistency in
outcome reporting. These statements refer researchers
to the Core Outcome Measures in Effectiveness Trials
(COMET) database for guidance [7]. A core outcome
set (COS) is defined as ‘the minimum [number of out-
comes] that should be measured and reported in all clin-
ical trials of a specific condition’ [8]. The COMET
Initiative was commissioned to encourage the develop-
ment and application of COS across health and social
care, create accessible information about guidelines on
outcome selection, and facilitate collaboration among re-
searchers developing COS. The initiative has received
widespread international support from organisations, in-
cluding Outcome Measures in Rheumatology (OMER-
ACT) [9] and the International Forum for Acute Care
Trialists (InFACT) [10]. InFACT aims to promote inter-
national collaboration in critical care research and address
barriers in undertaking trials, and is a major driving
force behind the advancement of creating COS for
critical care trials [10].
Using a Delphi study followed by a consensus meeting
is a widely accepted method of achieving consensus for
developing COS [8], but there are variations in how
feedback to the panel is provided during Delphi rounds.
Currently, there is no evidence as to which feedback
method will best achieve consensus that is representative
of all stakeholder groups. A systematic review of studies
using the Delphi technique to develop COS found no
evidence to identify which methods will yield consensus
that is genuinely representative of all stakeholder groups
[11]. When developing a COS important factors to take
into consideration are the inclusiveness of stakeholders
in the Delphi panel and the mechanism used to provide
feedback to the panel. Furthermore, once developed, it is
important to evaluate subsequent COS uptake in clinical
trials. Our Delphi study to develop a COS will address
both variation in selecting and defining outcome mea-
sures for ventilation trials, and will lay the foundation
for follow-up to examine uptake.
Aims and research questions
The primary aim is to develop a COS for trials involving
patients undergoing mechanical ventilation where an
aim of the intervention is to modify time spent on
mechanical ventilation. The secondary aims are to
determine the most valid method of gaining consensus
for a COS, and to evaluate the COS uptake 5 and 10
years after its publication.
Our research questions are:
1. Which outcomes are ranked by stakeholders as
critical for inclusion in the COS?
2. How is the ranking process influenced by the
method of stakeholder group feedback during Delphi
rounds?
3. Do Delphi panel participants rank the importance of
outcomes differently depending on their knowledge
of the other groups’ ranking?
4. Does participation by investigators in the Delphi
panel affect their subsequent use of the COS,
compared with investigators who do not participate?
Methods
We will use a mixed methods approach that incorpo-
rates a randomised trial nested within a Delphi study
and a consensus meeting. Subsequently, we will conduct
an observational cohort study to evaluate COS uptake in
published studies at 5 and 10 years following COS
publication.
Delphi study
We will use the Delphi technique to achieve input
from a broadly representative international and di-
verse stakeholder panel. Our Delphi study consists of
a series of sequential questionnaires or ‘rounds’ aim-
ing to obtain a consensus of opinion from a group of
expert stakeholders [12]. The Delphi technique can
also minimise response bias as individual feedback is
anonymised and not influenced by views of influential
individuals.
The Delphi panel
A range of expertise within the panel is considered to
be an important quality criterion for development of
COS [11]. We will therefore seek to include representa-
tives from seven key stakeholder groups that may be
particularly interested in this COS. The groups and
inclusion criteria are as follows:
1) Industry and pharmaceutical representatives – from
companies producing technology and products used
in mechanical ventilation.
2) Nurses and allied health professionals (NAHP) –
members of professional societies or associations
who have a primary role in clinical critical care
practice with a minimum of 5 years’ experience.
3) Physicians – members of professional societies or
associations who are consultant grade (or
equivalent) in intensive care, pulmonology or
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anaesthetics, and have a primary role in clinical
practice.
4) Research funding organisations – representatives
from funding bodies that have funded or
commissioned critical care research projects in the
last 5 years.
5) Patient support groups or charities – representatives
from respiratory or critical care charities; patient or
relatives user groups, forums or support groups,
preferably with personal experience of critical care.
6) Clinical trial groups (CTGs) – members of CTGs
that may include the Chair and other appropriate
members, preferably representing diverse
professions.
7) Trial investigators – primary and senior authors of
reports of clinical trials evaluating interventions
aiming to reduce duration of mechanical ventilation.
These will be identified from a systematic search of
publications in PubMed over the last 10 years.
Panel size and recruitment
There are no generally accepted guidelines for optimal
panel size to achieve stable consensus in Delphi studies
[13]. Panel size in other projects has usually been guided
by practicality, question scope and time available for
analysis [11]. We will attempt to recruit as large a panel
as possible, and will encourage all organisations within
each stakeholder group to nominate between five and
ten representatives who meet the inclusion criteria.
Organisations within each stakeholder group will be
identified through our wide network of critical care con-
tacts and through a methodological web-based search.
We will email study information to key contacts (for ex-
ample, Chair, President, Director) within organisations,
inviting them to nominate expert participants or to for-
ward a recruitment letter.
The French Cochrane Centre will undertake a system-
atic search of PubMed to identify trial investigators. This
search will include appropriate terms for: population
(adult and child); interventions (aimed at reducing
duration of mechanical ventilation); year of publication
(2004–2014); and study type (randomised trials, observa-
tional studies). We anticipate an overlap between eligible
participants identified through the PubMed search and
those identified by CTGs; therefore, we will only recruit
those participants not identified by the CTGs into the
trial investigator arm.
Previous studies of the Delphi technique demonstrate
high attrition after four rounds [10]. Therefore, we will
use three rounds and provide two-weekly reminders to
participants. Other techniques to minimise attrition in-
clude: provision of a personalised invitation and
reminders; an outline of timelines; and ensuring that
each round is concise and easy to complete with
minimal time commitment. Participants will receive an
email comprising a clear study explanation emphasising
the importance of completing all rounds, an estimate of
the amount of time to complete the questionnaires and
requesting consent for participation.
The Delphi questionnaire and rounds
The Delphi will be managed using a bespoke online
e-management system maintained by the COMET
Initiative. This system has previously been used in the
Management of Otitis Media with Effusion in Cleft
Palate (MOMENT) study developing a COS for trials in-
vestigating otitis media with effusion in children [14]. It
has been modified for this project to accommodate data
collection, randomisation process, web link to the rele-
vant questionnaire and presentation of scoring within
each round.
Round 1
We will use the most frequently reported outcomes
identified from our systematic review for the first Delphi
round. Participants will be asked to score each outcome
using the Grading of Recommendations Assessment,
Development and Evaluations (GRADE) scale of 1–9,
where 1 represents least important and 9 represents
most important [15]. Participants will have the option to
suggest additional outcomes for inclusion in the second
round. We will list outcomes in alphabetical order to
avoid potential weighting. Outcomes suggested during
round 1 will be reviewed and coded by two research
team members to ensure they represent new outcomes;
where uncertainty exists, the advisory group will be
consulted. Scores attributed to each outcome will be
calculated as a percentage of the total responses for all
scores. This will be summarised by stakeholder groups
and all outcomes will be carried forward to round 2. A
flowchart of the study is shown in Fig. 1.
We will collect demographic information from partici-
pants that will be stored in a separate database and used
to provide the participant with a unique identifier.
Participants will be asked to provide information on
their age, background, years of experience, field of inter-
est, working country and current position, to help to
define the composition of the panel.
Randomisation
After round 1, participants will be randomised to one of
three groups that will determine the method of feedback
they will receive. Participants will be stratified by type of
stakeholder to ensure equal representation in each study
group. The randomisation process will be conducted
through the COMET e-management system.
Study groups are as follows: group 1 will be shown
collated responses of the entire panel for each outcome
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(heterogeneous group); group 2 will be shown collated
responses for each outcome only from the stakeholder
group to which they belong (homogeneous group); and
group 3 will be shown collated responses for each out-
come for each stakeholder group (diverse group).
Rounds 2 and 3
In rounds 2 and 3, all three study groups will receive the
same list of outcomes with feedback tailored in accord-
ance with their randomisation. Participants will be asked
to reflect on their own response and the collated
responses, and score the outcomes again.
Analysis
During rounds, scores (1–9) will be calculated as a
percentage of the total responses. The final responses
will be analysed for each of the three study groups. We
will define consensus for outcome inclusion in the COS
as >70% of responses rating the outcome at 7 or greater
and not more than 15% of responses rating the
outcome <3 [14]. We will explore similarities and dif-
ferences across the three COS generated by the differ-
ent feedback methods. As there is no gold standard for
feedback, all three COS will be brought forward to the
consensus meeting for consideration and discussion,
and for the preparation of a final COS.
Ethical requirements
Individual participants will be approached (or will self-
volunteer) after nomination by an organisational lead
from an organisation with which they are affiliated.
Participants will be sent a short introductory email with
an information sheet about the study, including details
of randomisation, explicit details about what will be
involved and asked for their consent to participate.
Participants will be given the option to withdraw from
the study at any time. This study will be conducted
entirely online and consistent with standard practice in
survey research; consent will be assumed by agreement
to participate and completion of online questionnaires.
The study was reviewed and approved by the School of
Medicine, Dentistry and Biomedical Science Research
Ethics Committee at Queen’s University Belfast (QUB),
Northern Ireland, UK, in October 2014 [Ref: 14.34v2]
(Ethics Committee Reference). Sponsorship and indem-
nity is provided by QUB.
Consensus meeting
Following completion of the Delphi, we will invite repre-
sentatives of stakeholder groups from the Delphi panel,
COMET Initiative and the InFACT Outcomes Working
Group to the consensus meeting. To promote wide dis-
semination, we also will invite editors from key journals
(for example, American Journal of Respiratory and
Fig. 1 Flowchart of the Delphi study and nested randomised controlled trial
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Critical Care Medicine, Critical Care Medicine, British
Medical Journal, The Lancet, Intensive Care Medicine,
Critical Care) and funders of critical care trials. The
purpose of the consensus meeting is threefold, with the
common aim of reaching a consensus among those
present on the content of a core outcome set for mech-
anical ventilation. A report from this meeting will be
written up and published.
As described in the paper, participants with differing
professional backgrounds in the Delphi study will be
randomised into one of three groups, each using a differ-
ent feedback mechanism between rounds. Therefore, the
Delphi will produce three separate proposals for the
variables to include in the COS. It is likely that there will
be overlap between these three sets but they may also
differ in regard to the outcome variable types that they
contain. However, given that there is no gold standard in
Delphi studies for the best feedback mechanism to attain
consensus, we cannot be sure that the consensus on a
COS reached by any particular group is superior to that
reached by another of the groups, using a different
feedback mechanism. The research team will review the
consistency or variance between the three COS. If there
is consistency, then one COS will be brought to the
meeting, but if there is variance we will bring this to the
attention of the meeting for discussion and agreement
on choosing one particular COS. This is the first
purpose of the meeting.
The aim of the Delphi study is only to determine
‘what’ outcomes should be measured in mechanical
ventilation trials – it is not designed to determine ‘how’
the outcomes should be measured or, specifically, the
time point at which the outcome should be determined.
So, the second purpose of the consensus meeting is to
bring together experts in mechanical ventilation trials
alongside representatives of other organisations contrib-
uting to the development and/or dissemination of core
outcome measure sets, including OMERACT, InFACT
and COMET, to discuss ‘how’ the outcome variables in
the COS should be measured.
Fig. 2 Flowchart of randomisation in the observational cohort study. MV, mechanical ventilation
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The third purpose of the consensus meeting is to
invite editors from prominent critical care journals to
contribute, particularly to discussions on dissemination
of the core outcome set on mechanical ventilation.
Observational cohort study
We will conduct a prospective observational cohort
study to determine if participation of trial investigators
in the Delphi panel increases COS uptake in comparison
with investigators who did not participate, on the basis
of the use of the COS in published reports of clinical
trials in the decade after the COS is published.
Sample identification
We will conduct a PubMed search using terms relating to
mechanical ventilation, synonyms for ‘duration of mech-
anical ventilation’ and study design, to identify a cohort of
primary and senior authors that have published a trial in
this area in the past 10 years.
Methods
Study authors will be randomised to either participate in
the Delphi panel as a ‘trial investigator’ stakeholder
representative or not to participate (see Fig. 2). As we
are using data available in the public domain, informed
consent will not be sought from those not involved in
the Delphi. Participants involved in the Delphi will be
asked for informed consent in accordance with other
participating stakeholder groups.
Analysis
The primary outcome is the number and proportion of
authors who have used the COS in trials reported at 5
and 10 years after the publication of the COS. Data will
be compared between groups using the chi-square test.
A P value <0.05 will indicate a statistically significant
difference.
Discussion
This paper describes the design of a multi-method study
to develop a COS for ventilation trials in critical care,
explore the best Delphi feedback mechanism for achiev-
ing consensus and determine if participation increases
use of the COS in the long term. To our knowledge, it is
the first time that the Delphi technique incorporating
these methods has been used for developing a COS in
this topic area. Other important features of this study
are that it will provide guidance for designing Delphi
studies for developing COS in critical care and a data-
base of key stakeholder organisations that can be used
for development of other critical care COS. In addition
to developing the COS, this study may also shed light on
controversial aspects within critical care trials.
Study status
The Delphi study has not yet begun. Delphi panel mem-
bers are currently being recruited.
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